NEW YORK (GenomeWeb News) – Qiagen and Ventana Medical Systems jointly announced today that they have agreed to settle litigation regarding two expired patents covering human papillomavirus probes.
 
The firms said that they had mutually agreed to terms on Dec. 15 settling litigation of the expired patents, US Nos. 4,849,331 and 4,849,332.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.